Table 4.
Summary of metaregression analysis outputs for the variables that influenced the proportion of fever and two more symptoms at suspicious patients of leptospirosis.
| Variable | Estimate |
95% Confidence
interval |
P -value |
|---|---|---|---|
| Intercept | 1.2645 | (0.6342; 1.8949) | <0.0001 |
| Cross-sectional design | −0.2147 | (−0.6397; 0.2103) | 0.3220 |
| Longitudinal design | −0.2850 | (−0.6905; 0.1205) | 0.1683 |
| Asia | 0.0753 | (−0.2258; 0.3764) | 0.6241 |
| Europe | −0.0876 | (−0.4038; 0.2286) | 0.5871 |
| Latin-American and Caribbean | −0.0106 | (−0.2890; 0.2678) | 0.9404 |
| Serologic test | −0.1091 | (−0.5745; 0.2656) | 0.5719 |
| Serologic and molecular test | −0.1544 | (−0.5745; 0.2656) | 0.4711 |
| N | −0.0001 | (−0.0001; 0.0000) | 0.0642 |
| Positive Leptospira patients | 0.0002 | (−0.0000; 0.0003) | 0.0743 |
tau∧2 (estimated amount of residual heterogeneity): 0.0544 (SE = 0.0178).
tau (square root of estimated tau∧2 value): 0.2333.
I∧2 (residual heterogeneity/unaccounted variability): 99.92%.
H∧2 (unaccounted variability/sampling variability): 1201.95.
R∧2 (amount of heterogeneity accounted for): 0.00%.